Encephalopathy by hyperammonemia in the teenager
DOI:
https://doi.org/10.23938/ASSN.0140Keywords:
Hiperamoniemia. Ciclo de la urea.Abstract
Background. Hyperammonemia causes several alterations, mainly in the central nervous system. If hepatic failure is not its etiology, other less frequent causes must be investigated in the search for a definitive diagnosis. Clinical case. We report the case of a 16 year old patient admitted for acute encephalopathy and hyperammonemia. After analysis, brain CT, ultrasound and abdominal Doppler, we began empirical treatment of hyperammoniemia secondary to disorders of the urea cycle. We treated the brain edema and eliminated ammonia but we did not obtain favourable results and the patient died four days later. Conclusions. The complex management of hyperammonemia and the high morbidity and mortality involved require a multidisciplinary approach. Only early treatment and identification of the hyperammonemia’s etiology can avoid high morbidity and mortality in these patients.Downloads
References
1. CLAY AS, HAINLINE BE. Hyperammonemia in the ICU. Chest 2007; 132: 1367-1378.
https://doi.org/10.1378/chest.06-2940
2. MACÍAS MD, LÓPEZ M, MACÍA C, FERNÁNDEZ A. Hiponatremia aguda grave en un PACIENTE esquizofrénico potomano. An Sist Sanit Navar 2009, 32: 117-120.
https://doi.org/10.4321/S1137-66272009000100015
3. VILCHEZ JJ. Enfermedades del sistema nervioso por errores metabólicos CONGÉNITOS. Medicine 2003; 8: 5548-5557.
https://doi.org/10.1016/S0304-5412(03)71025-7
4. BRUSILOW SW, MAESTRI NE. Urea cycle disorders: diagnosis, PATHOPHYSIOLOGY and THERAPY. Adv Pediatr 1996; 43: 127-170.
https://doi.org/10.1016/S0065-3101(24)00072-0
5. SUMMAR ML, DOBBELAERE D, BRUSILOW S, LEE B. Diagnosis, symptoms, FREQUENCY and mortality of 260 patients with urea cycle disorders from a 21-year multicentre study of hyperammonaemia episodes. Acta Pediatr 2008; 97: 1420-1425
https://doi.org/10.1111/j.1651-2227.2008.00952.x
6. MORTON GB, GUDMUNDUR J, MARGOT U. Impact of acute and chronic low-dose glucocorticoids on protein metabolism. J Clin Endocrinol Metab 2007; 92: 3923-3929.
https://doi.org/10.1210/jc.2007-0951
7. KAMOUN PP, RABIER D. Valproate-induced inhibition of urea synthesis. Lancet 1987; 1: 48.
https://doi.org/10.1016/S0140-6736(87)90745-8
8. SUMMAR M. Current strategies for the management of neonatal urea cycle DISORDERS. J Pediatr 2001; 138: S30.
https://doi.org/10.1067/mpd.2001.111834
9. DARMAUN D, WELCH S, RINI A, SAGER BK, ALMOTARE A, HAYMOND MW. PHENYLBUTYRATE-induced glutamine depletion in humans: effect on leucine metabolism. Am J Physiol 1998; 274: E801-807.
https://doi.org/10.1152/ajpendo.1998.274.5.E801
10. GREEN TP, MARCHESSAULT RP, FREESE DK. Disposition of sodium benzoate in NEWBORN infants with hyperammonemia. J Pediatr 1983; 102: 785-790.
https://doi.org/10.1016/S0022-3476(83)80259-5
11. MSALL M, BATSHAW ML, SUSS R, BRUSILOW SW, MELLITS ED. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea cycle enzymopathies. N Engl J Med 1984; 310: 1500-1505.
https://doi.org/10.1056/NEJM198406073102304
12. Saudubray JM, TOUATI G, DELONLAY P, JOUVET P, NARCY C, LAURENT J et al. LIVER transplantation in urea cycle disorders. Eur J Pediatr 1999; 158 (Suppl 2): 55-59.
https://doi.org/10.1007/PL00014323
13. WHITINGTON PF, ALONSO EM, BOYLE JT, MOLLESTON JP, ROSENTHAL P, EMOND JC et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998; 21 (Suppl 1): 112-118.
https://doi.org/10.1023/A:1005317909946
14. MORIOKA D, KASAHARA M, TAKADA Y, SHIROUZU Y, TAIRA K, SAKAMOTO S et al. Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 2005; 11: 1332-1342.
https://doi.org/10.1002/lt.20587
15. PUPPI J, TAN N, MITRY RR, HEGHES RD, LEHEC S, MIELI-VERGANI G et al. HEPATOCYTE transplantation followed by auxiliary liver transplantation--a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 2008; 8: 452-457.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
